These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37418497)

  • 1. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    Parasitology; 2023 Nov; 150(13):1226-1235. PubMed ID: 37859414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Phenotypic Screening in
    Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
    mSphere; 2018; 3(1):. PubMed ID: 29359192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against
    Cajazeiro DC; Toledo PPM; de Sousa NF; Scotti MT; Reimão JQ
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015260
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo.
    Han RX; Jiang PC; Han B; Zhou HY; Wang YL; Guan JY; Liu ZR; He SY; Zhou CX
    Parasit Vectors; 2024 Feb; 17(1):59. PubMed ID: 38341599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
    Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y
    J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against
    Ma Y; Cao X; Wang H; Song X; Hu D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076987
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial dysfunction induced by bedaquiline as an anti-Toxoplasma alternative.
    Shi Y; Jiang Y; Qiu H; Hu D; Song X
    Vet Res; 2023 Dec; 54(1):123. PubMed ID: 38115043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
    El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain.
    Zhang JL; Si HF; Shang XF; Zhang XK; Li B; Zhou XZ; Zhang JY
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():27-34. PubMed ID: 30599391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acyl-CoA synthetase
    Charital S; Shunmugam S; Dass S; Alazzi AM; Arnold C-S; Katris NJ; Duley S; Quansah NA; Pierrel F; Govin J; Yamaryo-Botté Y; Botté CY
    mBio; 2024 Apr; 15(4):e0042724. PubMed ID: 38501871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives.
    Guo H; Gao Y; N'Da DD; Xuan X
    Onderstepoort J Vet Res; 2021 Jun; 88(1):e1-e8. PubMed ID: 34212734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fungal natural products with potent inhibition in
    Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
    Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicines for Malaria Venture Pandemic Box In Vitro Screening Identifies Compounds Highly Active against the Tachyzoite Stage of
    Dos Santos M; Oliveira Costa AL; Vaz GHS; de Souza GCA; Vitor RWA; Martins-Duarte ÉS
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising
    Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
    Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Description of Marinoquinoline Derivatives' Activity against
    Diethelm LTH; Ramos ABDSB; de Lorena GB; Trajano BI; do Espírito Santo RD; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Correia CRD; Reimão JQ
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.